Cosín J - Search Results

1

[Usefulness of trimetazidine in ischemia-reperfusion lesion. Experimental study in myocardial stunning model].

Morillas P, Hernández A, Pallarés V, Bertomeu V, Roldán FJ, Capdevilla C, Azorín I, Aguilar A, Portolés M, Cosín J. Morillas P, et al. Among authors: cosin j. Arch Cardiol Mex. 2004 Oct-Dec;74(4):262-70. Arch Cardiol Mex. 2004. PMID: 15709502 Spanish.

2

[NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure].

Rivera M, Taléns-Visconti R, Salvador A, Bertomeu V, Miró V, García de Burgos F, Climent V, Cortés R, Payá R, Pérez-Boscá JL, Mainar L, Jordán A, Sogorb F, Cosín J, Mora V, Diago JL, Marín F. Rivera M, et al. Among authors: cosin j. Rev Esp Cardiol. 2004 May;57(5):396-402. Rev Esp Cardiol. 2004. PMID: 15151773 Free article. Clinical Trial. Spanish.

3

[NT-proBNP and atrioventricular plane displacement. Relationship and diagnostic implications].

Rivera M, Cortés R, Mora V, Miró V, Cosín J, Jordán A, García de Burgos F, Salvador A, Sogorb F, Marín F, Climent V, Bertomeu V, Frutos A, Taléns R, Payá R, Pérez Boscá JL, Diago JL; Grupo de Estudio de la Disfunción Ventricular Izquierda de la Comunidad Valenciana. Rivera M, et al. Among authors: cosin j. Rev Esp Cardiol. 2003 Nov;56(11):1043-9. doi: 10.1016/s0300-8932(03)77013-4. Rev Esp Cardiol. 2003. PMID: 14622534 Free article. Spanish.

4

[Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].

de Velasco JA, Cosín J, de Oya M, de Teresa E; Grupo de investigadores del estudio PRESENTE. de Velasco JA, et al. Among authors: cosin j. Rev Esp Cardiol. 2004 Feb;57(2):146-54. Rev Esp Cardiol. 2004. PMID: 14967110 Free article. Spanish.

5

[Management of heart failure in cardiology and primary care (MICCAP) program: Improving the management of patients with heart failure].

Barrios V, Escobar C, Pallares V, Egocheaga MI, Lobos JM, Bover R, Gómez Doblas JJ, Cosín J. Barrios V, et al. Among authors: cosin j. Semergen. 2018 Nov-Dec;44(8):572-578. doi: 10.1016/j.semerg.2018.02.006. Epub 2018 Mar 26. Semergen. 2018. PMID: 29599063 Spanish.

6

[New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study].

De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Sellers G. De Velasco JA, et al. Among authors: cosin j. Rev Esp Cardiol. 2002 Aug;55(8):801-9. doi: 10.1016/s0300-8932(02)76708-0. Rev Esp Cardiol. 2002. PMID: 12199975 Free article. Spanish.

7

[Secondary prevention of myocardial infarction in Spain. The PREVERSE study].

de Velasco JA, Cosín J, López Sendón JL, de Teresa E, de Oya M, Carrasco JL, Navarro A. de Velasco JA, et al. Among authors: cosin j. Rev Esp Cardiol. 1997 Jun;50(6):406-15. Rev Esp Cardiol. 1997. PMID: 9304163 Free article. Clinical Trial. Spanish.

8

Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease.

Santos MT, Vallés J, Aznar J, Lago A, Sanchez E, Cosin J, Moscardó A, Piñón M, Broekman MJ, Marcus AJ. Santos MT, et al. Among authors: cosin j. J Lab Clin Med. 2006 May;147(5):220-7. doi: 10.1016/j.lab.2005.12.005. J Lab Clin Med. 2006. PMID: 16697769 Free PMC article.

9

Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation.

SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; Expert Reviewers for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; SEC Guidelines Committee; Working Group for the 2020 ESC guidelines for the management of atrial fibrillation; Expert reviewers for the 2020 ESC guidelines for the management of atrial fibrillation; SEC Guidelines Committee. SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation, et al. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):378-383. doi: 10.1016/j.rec.2020.11.023. Epub 2021 Mar 15. Rev Esp Cardiol (Engl Ed). 2021. PMID: 33736964 English, Spanish. No abstract available.

10

SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review.

Escobar C, Barrios V, Cosín J, Gámez Martínez JM, Huelmos Rodrigo AI, Ortíz Cortés C, Torres Llergo J, Requeijo C, Solà I, Martínez Zapata MJ. Escobar C, et al. Among authors: cosin j. Diabet Med. 2021 Mar;38(3):e14502. doi: 10.1111/dme.14502. Epub 2021 Jan 4. Diabet Med. 2021. PMID: 33368612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters